Literature DB >> 17020527

Current animal models of bronchial asthma.

I Kurucz1, I Szelenyi.   

Abstract

Human asthma is on the rise worldwide. The necessity to develop effective treatments against it requires an organized effort which covers every aspect of the disease from the pathological alterations via the genetic background to the use and development of active remedies. In these processes animal experiments have served an indispensable role. As asthma is not a natural disease in the animal kingdom the variety for artificially established animal models is quite wide. The possible selection ranges from the laboratory mouse to the horse, it includes ferret and sheep and even favorite pets such as cats and dogs. The large number of the models indicates that to some extent they might not be appropriate or it means that there is no generally accepted model of human asthma. Whatever the reason for this diversity animal models helped us to understand the detailed pathogenesis of some aspects of the disease, they helped us to develop compounds which are more active then previously used ones, and these models proved to us that human asthma is a unique, possibly species-specific disease the eradication of which requires a huge effort. This enormous task should include the collaboration of the clinical and basic research for the development of improved, advanced animal models, which in turn could strengthen our understanding about human asthma.

Entities:  

Mesh:

Year:  2006        PMID: 17020527     DOI: 10.2174/138161206778194169

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.

Authors:  Samah M Elaidy; Soha S Essawy; Mona A Hussain; Mohamed K El-Kherbetawy; Eman R Hamed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-30       Impact factor: 3.000

2.  Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Authors:  Albert Wu; Huaiyu Zheng; Jennifer Kraenzle; Ashley Biller; Carol D Vanover; Mary Proctor; Leslie Sherwood; Marlene Steffen; Chin Ng; Daniel J Mollura; Colleen B Jonsson
Journal:  ILAR J       Date:  2012

3.  A whole-genome scan for recurrent airway obstruction in Warmblood sport horses indicates two positional candidate regions.

Authors:  June E Swinburne; Helen Bogle; Jolanta Klukowska-Rötzler; Michaela Drögemüller; Tosso Leeb; Elizabeth Temperton; Gaudenz Dolf; Vincent Gerber
Journal:  Mamm Genome       Date:  2009-08       Impact factor: 2.957

4.  PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma.

Authors:  Raffaela Zaffini; Rosanna Di Paola; Salvatore Cuzzocrea; Marta Menegazzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-07       Impact factor: 3.000

5.  Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters.

Authors:  Mitchell S Wachtel; Goutam Shome; Mhairi Sutherland; John J McGlone
Journal:  BMC Immunol       Date:  2009-10-30       Impact factor: 3.615

6.  Investigating lung responses with functional hyperpolarized xenon-129 MRI in an ex vivo rat model of asthma.

Authors:  David M L Lilburn; Amanda L Tatler; Joseph S Six; Clémentine Lesbats; Anthony Habgood; Joanne Porte; Theodore Hughes-Riley; Dominick E Shaw; Gisli Jenkins; Thomas Meersmann
Journal:  Magn Reson Med       Date:  2015-10-28       Impact factor: 4.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.